TerminatedPhase 1NCT04749433

Study of [11C]CPPC to Assess the Safety and Tolerability in Patients With ALS

Studying Juvenile amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Johns Hopkins University
Principal Investigator
Nicholas J Maragakis, MD
Johns Hopkins University
Intervention
[11C]CPPC Injection(drug)
Enrollment
4 target
Eligibility
18 years · All sexes
Timeline
2021 – 2023

Study locations (1)

Collaborators

Precision Molecular

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04749433 on ClinicalTrials.gov

Other trials for Juvenile amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Juvenile amyotrophic lateral sclerosis →

← Back to all trials